A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers

8.2K views

⸱

DOI:

10.3791/53038

⸱

October 28th, 2015

 , 

In This Article

Summary

This protocol describes a method for the fabrication of conducting polymer nanoparticles blended with fullerene. These nanoparticles were investigated for their potential use as a next generation photosensitizers for Photodynamic Therapy (PDT).

Abstract

In this article a method for the fabrication and reproducible in-vitro evaluation of conducting polymer nanoparticles blended with fullerene as the next generation photosensitizers for Photodynamic Therapy (PDT) is reported. The nanoparticles are formed by hydrophobic interaction of the semiconducting polymer MEH-PPV (poly[2-methoxy-5-(2-ethylhexyloxy)-1,4-phenylenevinylene]) with the fullerene PCBM (phenyl-C61-butyric acid methyl ester) in the presence of a non-compatible solvent. MEH-PPV has a high extinction coefficient that leads to high rates of triplet formation, and efficient charge and energy transfer to the fullerene PCBM. The latter processes enhance the efficiency of the PDT system through fullerene assisted triplet and radical formation, and ultrafast deactivation of MEH-PPV excited stated. The results reported here show that this nanoparticle PDT sensitizing system is highly effective and shows unexpected specificity to cancer cell lines.

Introduction

In Photodynamic Therapy (PDT) photosensitizers are administered to target tissue, and upon exposure to light the photosensitizer generates Reactive Oxygen Species (ROS). ROS species such as singlet oxygen and superoxide can induce oxidative stress and subsequent structural damage to cells and tissue1-4. Due to its ease of application this method has been actively investigated and clinical trials have taken place5,6. However, significant issues such as dark toxicity of the sensitizers, patient sensitivity to light (due to non-selective distribution of the sensitizer), and hydrophobicity of the sensitizers (which leads to reduced bioavailability an....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Culturing Cell Lines

  1. Thaw TE 71 (Mouse thymic epithelial cells), MDA-MB-231 (Human breast cancer cells), A549 (Human lung cancer cells) and OVCAR3 (Human ovarian tumor cells) by holding the cryogen vials in warm water for less than 2 min. Add 10 ml DMEM media supplemented with 10% FBS to each cell line and centrifuge for 6 min at 106 x g.
  2. Aspirate the suspension and add 3ml media to the pellet. Mix the cells properly by pipetting several times. Add this cell solution to pre-warmed 7 ml DMEM media supplemented with 10% FBS in T75 flasks and keep the flasks in humidified atmosphere of 95% air/ 5% CO2 at 37 °C. Label this flask as....

Access restricted. Please log in or start a trial to view this content.

Results

Uptake and intrinsic cytotoxicity of nanoparticles

The 50 wt% blended MEH-PPV/PCBM nanoparticles were incubated with TE 71, MDA-MB-231, A549 and OVCAR3 cell lines. The PCBM blending level was chosen as 50 wt% PCBM, which has been shown to provide ideal charge and energy transfer properties between conjugated polymers and fullerenes14. Fluorescence images of nanoparticle uptake are shown in Figure 1B. Cells were incubated for 24 hr with nanoparticles to ensure nanopa.......

Access restricted. Please log in or start a trial to view this content.

Discussion

To achieve nanoparticle uptake it was necessary to maintain some critical measures while fabricating the nanoparticles. A 10-6 M MEH-PPV solution (blended with 50 wt% PCBM) in THF was prepared to inject into DI water, as it was observed that the concentration of this solution plays an important role in determining the size of nanoparticles being formed. Concentration was checked by UV-vis spectroscopy. Note that in protocol step 2.1.3 it was necessary to dilute the initially prepared MEH-PPV solution (undilute.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

The authors gratefully acknowledge the National Science Foundation (NSF) for financial support of this work through a CAREER award (CBET-0746210) and through award CBET-1159500. We would like to thank Dr. Turkson (Univ. of Hawaii Cancer Center) and Dr. Altomare (Univ. of Central Florida College of Medicine) for assistance with cell culture.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Poly[2-methoxy-5-(2-ethylhexyloxy)-1,4-phenylenevinylene] (MEH-PPV)Sigma Aidrich536512-1Gaverage Mn 150,000-250,000
[6,6]-Phenyl C61 butyric acid methyl ester (PCBM)Sigma Aidrich684449-500MG>99.5%
Tetrahydrofuran (THF)EMDTX0284-6Drisolv
1 ml syringeNational Scientific Company37510-1For filtration of MEH-PPV solution
Syringe filterVWR28145-49525 mm, 0.2 µm, PTFE
1 ml syringeHamilton Company81320For injection of MEH-PPV solution into water to make nanoparticles
Dulbecco's Modification of Eagle's Medium/Ham's F-12 50/50 Mix (DMEM)Corning (VWR)45000-350
Hank's Balanced Salt Solution without phenol red (HBSS)Quality Biological (VWR)10128-740
Dulbecco's Phosphate-Buffered Saline, 1x without calcium and magnesium (DPBS)Corning (VWR)45000-436
Fetal Bovine Serum, Regular (Heat Inactivated) (FBS)Corning (VWR)45000-736
Trypsin EDTA 1x 0.25%Corning (VWR)45000-664Trypsin/2.21 mM EDTA in HBSS without sodium bicarbonate, calcium and magnesium Porcine Parvovirus Tested
16% ParaformaldehydeElectron Microscopy Sciences 1571016% paraformaldehyde is diluted to 4% by adding PBS
DAPI Biotium VWR89139-054Nuclear stain
5 ml pipettesVWR82050-478
75 cm2 culture flaskVWR82050-856for culturing cells
96-well platesVWR82050-771for MTT assays
Tissue Culture Dishes with VentsGreiner Bio-One (VWR)82050-538
Propidium iodideMolecular probesP3566
Annexin V FITCInvitrogenA13199dye for apoptosis
Celltiter 96 non-R 1000 assaysPromega (VWR)PAG4000MTT
CellROX Green Reagent, for oxidative stress detectionInvitrogenC10444For ROS detection
UV-vis spectrometerAgilent 8453
Fluorescence spectrometerNanoLog HoribaJobin Yvon
Dynamic light scatteringPD2000DLS, Precision detector
IncubatorNuAir DH Autoflow
Confocal microscopeZeiss Axioskop263X oil immersion objective lens
Epiluminescence microscopeOlympus IX7160X water immersion objective lens, Andor Zyla sCMOS camera
Solar SimulatorNewport 67005 Oriel Instruments
Reference solar cellOriel VLSI Standards Incorporated
Microplate readerBioTek Ex808
HemocytometerHausser Scientific Partnership3200For counting cells

References

  1. Dolmans, D., Fukumura, D., Jain, R. K. Photodynamic therapy for cancer. Nat Rev Cancer. 3 (5), 380-387 (2003).
  2. Dougherty, T. J., et al. Photodynamic therapy. J Natl Cancer Inst. 90 (12), 889-905 (1998).
  3. Ferrari, M.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Conducting Polymer NanoparticlesFullerene PCBMNanoparticle FabricationPrecipitation MethodCell Uptake AnalysisROS DetectionMTT AssayFluorescence ImagingSolar Simulator